Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive
fibrosing interstitial pneumonia of unknown cause and limited to the lungs. Schisandrae …

Pulmonary fibrosis (PF) is a serious progressive fibrotic disease that is characterized by
excessive accumulation of extracellular matrix (ECM), thus resulting in stiff lung tissues …

Abstract Purpose/Aim: Pulmonary fibrosis (PF) is characterized by the progressive and
ultimately fatal accumulation of fibroblasts and extracellular matrix in the lung that distorts its …

Pulmonary fibrosis, a progressive and lethal lung disease, is a major therapeutic challenge
for which new therapeutic strategies are warranted. Schisandrin B (Sch B) and Glycyrrhizic …

Background Idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fibrosing interstitial
lung disease, is associated with extremely poor prognosis, and lacks effective treatment. The …

Background Pulmonary fibrosis (PF) is a difficult clinical condition with no effective treatment
and a high mortality rate. Patients usually die of respiratory failure. In the present, we …

Idiopathic pulmonary fibrosis (IPF) is a refractory interstitial lung disease for which there is
no effective treatment. Although the pathogenesis of IPF is not fully understood, TGF-β and …

Background and aim: Pro-inflammatory macrophages aggravated progress of pulmonary
fibrosis (PF) both in patients and animal models. Fuzheng Huayu (FZHY) formula, a Chinese …

Idiopathic pulmonary fibrosis is a progressive and lethal form of interstitial lung disease that
lacks effective therapies at present. Glycyrrhizic acid (GA), a natural compound extracted …

Objectives Barbaloin is one of the main bioactive ingredients extracted from Aloe vera,
which has the property of protecting the lung from LPS-induced acute injury; however, the …